Coincidence of Five Primary Melanomas in One Patient
Authors:
V. Paťavová 1; L. Drlík 1; L. Slezáková 1; L. Pock
Authors‘ workplace:
Dermatovenerologické oddělení, Nemocnice Šumperk, a. s., přednosta prim. MUDr. Lubomír Drlík
1; Bioptická laboratoř s. r. o., Plzeň, odborná vedoucí lékařka prof. MUDr. Alena Skálová, CSc.
2
Published in:
Čes-slov Derm, 90, 2015, No. 4, p. 164-167
Category:
Case Reports
Overview
The authors describe a case of a man who was simultaneously diagnosed with nodular melanoma, two superficial and two in situ melanomas. Development of multiple primary melanomas is a rare but well recognized disease, with an estimated incidence ranging from 1.75% to 8.5% in melanoma patients. The diagnosis of primary melanoma increases the risk of additional primary melanomas. A total skin examination has therefore to be performed during follow up of melanoma patients for early detection of further malignant melanomas.
Key words:
melanoma – multiple occurence – CDKN2A mutation
Sources
1. BLACKWOOD, M. A., HOLMES, R., SYNNESTVEDT, M. et al. Multiple primary melanoma revised. Cancer, 2002, 15, 94, 8, p. 2248–2255.
2. BORG, A., SANDBERG, T., NILSSON, K. et al. Hight frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. Natl. Cancer Inst., 2000, 2, 92, 15, p. 1260–1266.
3. BOWER, M. R., SCOGGINS, C. R., MARTIN, R. C. et al. Second primary melanomas: incidence and outcome. Am. Surg., 2010, 76, 7, p. 675–681.
4. CARLI, P., DeGIORGI, V., CHIURAGI, A. et al. Multiple synchronous cutaneous melanomas: implications for prevention. Int. J. Dermatol., 2012, 41, 9, p. 583–585.
5. CONRAD, N., LEIS, P., ORENGO, I. et al. Multiple primary melanoma. Dermatol. Surg., 1999, 25, 7, p. 576–581.
6. FERRERES, J. R., MORENO, A., MARCOVAL, J. Multiple primary melanoma. Act. Dermosif., 2009, 100, 5, p. 414–419.
7. HILL, V. K., GARTNER, J. J., SAMUELS, Y. et al. The genetics of melanoma: recent advances. Ann. Rev. Genomics Hum. Genet., 2013, 14, p. 257–279.
8. HWA, C., PRICE, L. S., BELITSKAYA-LEVY, I. et al. Single versus multiple primary melanomas: old questions and new answers. Cancer, 2012, 118, 17, p. 4184–4192.
9. JOHNSON, T. M., HAMILTON, T., LOWE, L. Multiple primary melanomas. JAAD, 1998, 39, 3, p. 422–427.
10. LANDTHALER, M., BRAUN-FALCO, O., BERNREITER, F. et al. Multiple primary malignant tumors in patients with malignant melanoma of the skin. Hautarzt, 1992, 43, 1, p. 11–13.
11. LAPINS, J., EMTESTAM, L., HEDBLAD, M. A. Synchronous multiple primary melanoma are often missed. Increased attention to the patient’s entire skin is required for early diagnosis. Lakartidningen, 2013, 110, 8, p. 410–412.
12. PACK, G. T., SCHARNAGEL, I. M., HILLYER, R. A. Multiple primary melanoma. Cancer, 1952, 5, 6, p. 1110–1115.
13. POLLIO, A., TOMASI, A., PELLACANI, G. et al. Multiple primary melanomas versus single melanoma of the head and neck: a comparsion of genetic, diagnostic, and therapeutic implications. Melanoma Res., 2014, 24, 3, p. 267–272.
14. PUIG, S., MALVEHY, J., BADENAS, C. et al. Role of the CDKN2A locus in patients with multiple primary melanomas. J. Clin. Oncol., 2005, 1, 23, 13, p. 3043–3051.
15. SAVOIA, P., QUAGLINO, P., VERRONE, A. et al. Multiple primary melanomas: analysis of 49 cases. Melanoma Res., 1998, 8, 4, p. 361–366.
16. SCHMID-WENDTNER, M. H., BAUMERT, J. et al. Risk of second primary malignancies in patients with cutaneous melanoma. Br. J. Dermatol., 2001, 145, 6, p. 981–985.
17. SLINGLUFF, C. L. jr., VOLLMER, R. T., SEIGLER, H. F. Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery, 1993, 113, 3, p. 330–339.
18. SOLÍS-ARIAS, M. P., LAMMOGLIA-ORDIALES, L., TOUSSAINT-CARIE, S. et al. Melanoma primario múltiple (MMP) sincrónico: caso clínico y revisión de la literatura. Gac. Med. Mex., 2014, 150, 1, p. 101–105.
19. TITUS-ERNSTOFF, L., PERRY, A. E., SPENCER, S. K. et al. Multiple primary melanoma: two-year results from a population-based study. Arch. Dermatol., 2006, 142, 4, p. 433–438.
20. VASEN, H. L., GRUIS, N. A., FRANTS, R. R. et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma assotiated with a specific 19 deletion of p16 (p16-Leiden). Int. J. Cancer, 2000, 15, 87, 6, p. 809–811.
21. VOJÁČKOVÁ, N., HEJEMANOVÁ, I., SCHMIEDBERGEROVÁ, R., HERCOGOVÁ, J. Výskyt druhé primární malignity v souboru nemocných s maligním melanomem sledovaných na Dermatovenerologické klinice 2. LF UK a FN Na Bulovce. Retrospektivní analýza. Čes.-slov. Derm., 2005, 80, 3, s. 169–172.
Labels
Dermatology & STDs Paediatric dermatology & STDsArticle was published in
Czech-Slovak Dermatology
2015 Issue 4
Most read in this issue
- Autoinflammatory Syndromes with Skin Manifestations
- Coincidence of Five Primary Melanomas in One Patient
- Significance of Serum Levels of CRP, Lp-PLA2, Leptin and Lipocalin 2 in Patients with Psoriasis